Gilead Agrees To Pay $40M To Settle Claims It Held Back Safer HIV Drug
OAKLAND, Calif. — Gilead Sciences Inc. has agreed to pay up to $40 million to settle the claims of more than 2,600 plaintiffs who allege that they suffered injuries to their...To view the full article, register now.
Already a subscriber? Click here to view full article